ANAVEX 3-71, also known as AF710B, is a muscarinic acetylcholine M1 receptor positive allosteric modulator and sigma σ1 receptor agonist which is under development for the treatment of schizophrenia, Alzheimer's disease, frontotemporal dementia, other neurodegenerative disorders, and Parkinson's disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.